advertisement

Skin

27 October 2011

Experimental psoriasis drug significantly better

An experimental psoriasis treatment performed significantly better than the commonly prescribed medication methotrexate in a new clinical trial.

An experimental psoriasis treatment performed significantly better than the commonly prescribed medication methotrexate in a new clinical trial.

Results of the study are published in the issue of the New England Journal of Medicine. The study was funded by the drug's manufacturer, Abbott Laboratories.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.